Quality of Life and Sexual Function in Vaginal Aplasia Patients After Davydov Procedure
Assessing Quality of Life and Sexual Function in Vaginal Aplasia Patients After Neovaginal Surgical Procedure by Davydov Method
1 other identifier
observational
29
1 country
1
Brief Summary
Mayer-Rokitansky-Kuster-Hauser(MRKH) syndrome is described as absence or underdevelopment of vagina and uterus. This condition is extremely rare congenital malformation that affects one in every 5000 female births. Medical management of MRKH syndrome includes the creation of a neovagina using nonsurgical or surgical procedure. In Vietnam, since 2014, Davydov technique has been used to create neovagina for patients with MRKH syndrome at Tu Du hospital which is the biggest obstetric and gynecological hospital in south of Vietnam. However, the effectiveness of this surgical approach on patient's life and sexual activity hasn't been assessed. The objective of this study is to assess the quality of life, the psychological impact and the sexual function of Vietnamese women with MRKH syndrome after Davydov surgical procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2021
CompletedFirst Posted
Study publicly available on registry
June 11, 2021
CompletedStudy Start
First participant enrolled
December 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2022
CompletedNovember 18, 2022
November 1, 2022
3 months
May 21, 2021
November 14, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Quality of Life of women with vaginal agenesis after Davydov procedure
The psychological doctor uses the questionnaire named World Health Organization Quality of Life Scale(WHOQoL-BREF) in the interview to ask patient. The patient's Quality of Life will be assessed based on the WHOQoL-BREF questionnaire 's score. All the results will be collected and calculated subsequently. The raw scores are converted to transformation scores. The first transformation converts scores to range of 4-20 and the second transformation converts domain scores to 0-100 scale. Higher scores reflect better Quality of Life.
From six months after surgery up to the initiation of the study, assessed up to 1 month
Sexual Function of women with vaginal agenesis after Davydov procedure
The psychological doctor uses the questionnaire named Female Sexual Function Index Scale (FSFI) in the interview to ask patient. The patient's sexual function will be assessed based on the FSFI questionnaire 's score. All the results will be collected and calculated subsequently. The FSFI's minimum total score is 2 and the FSFI's maximum total score is 36. The patient is diagnosed to have sexual dysfunction when the FSFI's total score is less than 26,55.
From six months after surgery up to the initiation of the study, assessed up to 1 month
Eligibility Criteria
Sample is patients who underwent Davydov procedure to create neovagina at Tu Du hospital, Ho Chi Minh city, Vietnam.
You may qualify if:
- Aged equal or more than 18.
- Diagnosed vaginal agenesis and underwent Davydov procedure to create neovagina at least 6 months.
- Able to listen, understand and answer questions.
You may not qualify if:
- Disagreed to participate the research.
- Having any conditions that make patient unable to listen, understand and answer questions.
- Having psychological disturbance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tu Du Hospital
Ho Chi Minh City, Vietnam
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lan TN Vuong, PhD
University of Medicine and Pharmacy at Ho Chi Minh City
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
May 21, 2021
First Posted
June 11, 2021
Study Start
December 13, 2021
Primary Completion
February 28, 2022
Study Completion
November 10, 2022
Last Updated
November 18, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share